OncoOne
PrivateLast Round
Series B
Apr 1, 2022
Total Funding Raised
$14.26M
Company Overview
OncoOne is a biotechnology company that develops precision medicines for cancer and chronic inflammatory diseases using its proprietary antibody-based targeting platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoOne Comparables
Compare OncoOne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PreTT ApS | 78% | |
| Y-mAbs Therapeutics | 76% | |
| Akiram Therapeutics | 76% | |
OncoOne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 1, 2022 | ||||
| Series A | Mar 18, 2020 |
Key People
Founding team and executive leadership
OncoOne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Austria Wirtschaftsservice | Series A |
| FFG Austrian Research Promotion Agency | Series A |
OncoOne Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncoOne's valuation, stock price, and market status.